Synergistic effect of fatty liver and smoking on metabolic syndrome

doi:10.3748/wjg.15.5334

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 42

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2771)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-5) series.

Item

Count

PDF

301

HTML

2338

Tables (1-5)

132

Sum=2771

Nov 14, 2009 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Nov 14, 2009; 15(42): 5334-5339
Published online Nov 14, 2009. doi: 10.3748/wjg.15.5334

Table 1 Demographic data and lifestyle factors among study subjects (n = 3455), stratified by fatty liver and smoking habit (mean ± SD) n (%)

	Fatty liver (-)		Fatty liver (+)		P-value
	Non-smoker (n = 1702)	Smoker (n = 365)	Non-smoker (n = 1057)	Smoker (n = 331)	P-value
Age (yr)	45.9 ± 11.9	42.6 ± 10.8	49.9 ± 11.0	44.9 ± 9.4	< 0.0001
BMI (kg/m²)	22.0 ± 2.6	22.3 ± 2.7	25.7 ± 3.2	25.9 ± 3.0	< 0.0001
Male	681 (40)	290 (79.5)	695 (65.8)	315 (95.2)	< 0.0001
Drinking¹	127 (7.5)	99 (27.1)	122 (11.5)	93 (28.1)	< 0.0001
Physical activity²	944 (55.5)	242 (66.5)	568 (53.8)	223 (67.4)	< 0.0001

¹Alcohol consumption ≥ 1 time and ≤ 3 times per week (subjects who drank more than 3 times per week were excluded before analysis);

²Exercise ≥ 1 time per week. BMI: Body mass index.

Table 2 Clinical and biochemical characteristics of study subjects (n = 3455) classified by fatty liver and smoking habit (mean ± SD)

	Fatty liver (-)		Fatty liver (+)		P-value
	Non-smoker (n = 1702)	Smoker (n = 365)	Non-smoker (n = 1057)	Smoker (n = 331)	P-value
WC (cm)	79.9 ± 8.3	80.8 ± 7.4	88.1 ± 8.5	88.8 ± 7.4	< 0.0001
FPG (mg/dL)	89.2 ± 19.3	89.8 ± 21.4	101.9 ± 33.4	99.7 ± 33.4	< 0.0001
SBP (mmHg)	113.9 ± 19.8	111.8 ± 16.8	125.9 ± 20.1	122.4 ± 18.8	< 0.0001
DBP (mmHg)	68.6 ± 11.3	69.7 ± 10.9	76.5 ± 11.4	78.1 ± 10.6	< 0.0001
TG (mg/dL)	97.7 ± 49.5	130.1 ± 74.3	170.6 ± 129.3	225.9 ± 238.5	< 0.0001
HDL-C (mg/dL)	60.1 ± 14.9	52.6 ± 13.8	48.9 ± 11.4	44.3 ± 12.6	< 0.0001

WC: Waist circumference; FPG: Fasting plasma glucose; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; TG: Triglyceride; HDL-C: High-density lipoprotein cholesterol.

Table 3 Prevalence of metabolic risk factors and metabolic syndrome among study subjects (n = 3455) classified by fatty liver and smoking habit n (%)

	Fatty liver (-)		Fatty liver (+)		P-value
	Non-smoker	Smoker	Non-smoker	Smoker	P-value
Central obesity¹	497 (29.2)	51 (14.0)	501 (47.4)	137 (41.4)	< 0.0001
FPG ≥ 100 mg/dL	164 (9.6)	40 (11.0)	317 (30.0)	76 (23.0)	< 0.0001
High blood pressure²	356 (20.9)	63 (17.3)	477 (45.1)	119 (36.0)	< 0.0001
TG ≥ 150 mg/dL	207 (12.2)	103 (28.2)	478 (45.2)	197 (59.5)	< 0.0001
Low HDL-C³	223 (13.1)	71 (19.5)	320 (30.6)	147 (44.4)	< 0.0001
Metabolic syndrome	123 (7.2)	33 (9.0)	364 (34.4)	121 (36.6)	< 0.0001

¹Waist circumference in men ≥ 90 cm or in women ≥ 80 cm;

²Systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg;

³High-density lipoprotein cholesterol in men < 40 mg/dL or in women < 50 mg/dL.

Table 4 ORs for metabolic risk factors and metabolic syndrome among subgroups of subjects, analyzed by multiple logistic regression, adjusted for age, gender, drinking alcohol, and physical activity (n = 3455)

	Fatty liver (-)				Fatty liver (+)
	Non-smoker (n = 1702)		Smoker (n = 365)		Non-smoker (n = 1057)		Smoker (n = 331)
	OR	95% CI	OR	95% CI	OR	95% CI	OR	95% CI
Central obesity¹	1 (reference)		0.7	0.5-1.1	3.5^a	2.9-4.2	4.5^a	3.3-6.1
FPG ≥ 100 mg/dL	1 (reference)		1.3	0.8-1.9	3.6^a	2.9-4.6	2.8^a	2.0-4.1
High blood pressure²	1 (reference)		0.7	0.5-1.0	2.7^a	2.2-3.2	1.7^a	1.3-2.3
TG ≥ 150 mg/dL	1 (reference)		2.4^a	1.8-3.2	5.3^a	4.4-6.5	8.1^a	6.0-10.9
Low HDL-C³	1 (reference)		2.0^a	1.4-2.7	3.4^a	2.7-4.1	8.3^a	6.1-11.3
Metabolic syndrome	1 (reference)		1.4	0.9-2.2	6.6^a	5.2-8.4	9.5^a	6.7-13.4

^aP < 0.05.

¹Waist circumference in men ≥ 90 cm or in women ≥ 80 cm;

²Systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg;

³High-density lipoprotein cholesterol in men < 40 mg/dL or in women < 50 mg/dL. OR: Odds ratio; CI: Confidence interval.

Table 5 ORs for metabolic risk factors and metabolic syndrome among fatty liver groups, analyzed by multiple logistic regression, adjusted for age, gender, drinking alcohol, and physical activity (n = 1388)

	Fatty liver (+)
	Non-smoker (n = 1057)		Smoker (n = 331)
	OR	95% CI	OR	95% CI
Central obesity¹	1 (reference)		1.2	0.9-1.6
FPG ≥ 100 mg/dL	1 (reference)		0.7	0.5-1.1
High blood pressure²	1 (reference)		0.6	0.5-0.9
TG ≥ 150 mg/dL	1 (reference)		1.5^a	1.2-2.0
Low HDL-C³	1 (reference)		2.7^a	2.0-3.7
Metabolic syndrome	1 (reference)		1.3^a	1.0-1.8

^aP < 0.05.

¹Waist circumference in men ≥ 90 cm or in women ≥ 80 cm;

²Systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg;

³High-density lipoprotein cholesterol in men < 40 mg/dL or in women < 50 mg/dL.

Citation: Chiang PH, Chang TY, Chen JD. Synergistic effect of fatty liver and smoking on metabolic syndrome. World J Gastroenterol 2009; 15(42): 5334-5339
URL: https://www.wjgnet.com/1007-9327/full/v15/i42/5334.htm
DOI: https://dx.doi.org/10.3748/wjg.15.5334